The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

Abstract Background Limited data are available regarding the ability of biomarkers to predict complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Complete response translates to better patient survival. DEK is a transcription factor involved not only in...

Full description

Bibliographic Details
Main Authors:	J. Martinez-Useros, I. Moreno, M. J. Fernandez-Aceñero, M. Rodriguez-Remirez, A. Borrero-Palacios, A. Cebrian, T. Gomez del Pulgar, L. del Puerto-Nevado, W. Li, A. Puime-Otin, N. Perez, M. S. Soengas, J. Garcia-Foncillas
Format:	Article
Language:	English
Published:	BMC 2018-02-01
Series:	BMC Cancer
Subjects:	DEK Chemoradiotherapy Neoadjuvant treatment Rectal cancer Predictive biomarker Complete pathological response
Online Access:	http://link.springer.com/article/10.1186/s12885-018-4048-8

Similar Items

Oncogenic Phenotypes Induced by Overexpression of the DEK Proto-oncogene
by: Matrka, Marie C.
Published: (2017)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

The potential role of DEK over-expression in the radiation response of head and neck cancer
by: Hui Xiao, et al.
Published: (2021-03-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

Is Margin Status Less Prognostic After Neoadjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma?
by: Callery, M.P, et al.
Published: (2022)

DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages
by: Nicholas A. Pease, et al.
Published: (2020-07-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)
by: Hai-Bo Sun, et al.
Published: (2020-04-01)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Neoadjuvant Radiotherapy/Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
by: Deniz Yalman
Published: (2015-03-01)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
by: Song J, et al.
Published: (2020-08-01)

DEK Protein as a Potential Radio-protective Agent for Hematopoietic Stem Cells (HSCs) and Hematopoietic Progenitor Cells (HPCs) in Mice
by: Sharma, Itee
Published: (2018)

PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma
by: Edge, S.D., et al.
Published: (2021)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
by: Ali Kermani, et al.
Published: (2020-01-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Preoperative chemoradiotherapy for locally advanced gastric cancer
by: Pepek Joseph M, et al.
Published: (2013-01-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers
by: Liu X, et al.
Published: (2021-04-01)

Anomalies d'épissage dans les leucémies aigues myéloblastiques : rôle de WT1 et de DEK et impact clinique
by: Mint Mohamed, Aminetou
Published: (2015)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
by: Dong-Bin Wang, et al.
Published: (2016-01-01)

MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
by: Zhang W, et al.
Published: (2020-09-01)

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
by: Hai-Yu Zhou, et al.
Published: (2020-07-01)

Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Zhang Y, et al.
Published: (2020-09-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

DEK modulates both expression and alternative splicing of cancer‑related genes
by: Liu, B., et al.
Published: (2022)

Prognostic Impact of Pretreatment Elevated and Normalized Carcinoembryonic Antigen Levels After Neoadjuvant Chemoradiotherapy in Resected Locally Advanced Rectal Cancer Patients
by: Song J, et al.
Published: (2021-05-01)

Perkuatan Pelat Jembatan Dek Baja dengan Overlay Beton Bertulang
by: Made Sukrawa, et al.
Published: (2011-12-01)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
by: Bo Jan Noordman, et al.
Published: (2018-02-01)

Creative and Literary Works - Selected Poems(dthaa yai, dek pom daeng, kae piang, kohn dieow)
by: Jai Arun Ravine
Published: (2010-01-01)

Neoadjuvant Treatment in Pancreatic Cancer
by: Atsushi Oba, et al.
Published: (2020-02-01)

The Role of the Human DEK Oncogene in the Regulation of DNA Damage Response and Repair
by: Kavanaugh, Gina M.
Published: (2011)

Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells
by: Allie N. Greene, et al.
Published: (2020-11-01)

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
by: Q. P. Janssen, et al.
Published: (2021-03-01)

Targeting the DEK oncogene in head and neck squamous cell carcinoma: functional and transcriptional consequences
by: Adams, Allie K.
Published: (2015)

Is long interval from neoadjuvant chemoradiotherapy to surgery optimal for rectal cancer in the era of intensity-modulated radiotherapy?: a prospective observational study
by: Chang H, et al.
Published: (2018-09-01)

results of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Comparative efficiency of hypofractionation and classical fractionation schedules
by: A. S. Abdujapparov, et al.
Published: (2020-08-01)

Evaluation of Clinical Response to Neoadjuvant Chemoradiotherapy and its Comparison with Postoperative Pathologic Response in Patients with Esophageal Cancer in “5th December” Hospital in Gorgan
by: Ali Arian Nia, et al.
Published: (2018-01-01)